Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Ovarian cancer as a related topic and added MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer lists the condition 'Ovarian cancer' and the related topic 'MedlinePlus Genetics'.SummaryDifference0.5%

- Check41 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check48 days agoChange DetectedUpdate to revision v3.1.0 and new contact numbers added; removal of a Genetic and Rare Diseases Information Center resource on ovarian cancer (v3.0.2).SummaryDifference0.5%

- Check62 days agoChange DetectedPage revised to v3.0.2; 'Back to Top' link removed. No substantive content changes detected.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.